Commodore Capital L.P., 10% Owner at Satsuma Pharmaceuticals, Inc. (STSA), bought 120,890 shares at $5.51 ($659K) on 2021-10-22, disclosed to the SEC on 2021-10-25.
Open-market purchase of $659k STSA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.40 | 32,816 | $177K | 26.9% |
| 2 | $5.40 | 32,816 | $177K | 26.9% |
| 3 | $5.51 | 27,629 | $152K | 23.1% |
| 4 | $5.51 | 27,629 | $152K | 23.1% |
| Total | $5.45 avg | 120,890 | $659K | 100% |
| Filing → |
| VERA | BUY | 2023-06-22 | $13.6M | — | Filing → |
| ELVN | BUY | 2023-02-27 | $14K | — | Filing → |
| IMRA | BUY | 2023-02-23 | $284K | — | Filing → |